August

27

Liquid Biopsy Detection of a TP53 Variant in a “Disease Free” Pediatric Patient: Challenges in Interpretation

11:00am - 12:00pm ET

Explore the cutting-edge realm of liquid biopsy testing in cancer diagnostics with Drs. Patrick Blackburn and Selene Koo. This course delves into the emerging role of Plasma-derived cell-free DNA (cfDNA) testing as a non-invasive adjunct to traditional biopsies, showcasing its potential in detecting tumor variants and its application in cancer surveillance. Join us to gain invaluable insights into the advantages, limitations, and pitfalls of this revolutionary approach. Presented by Patrick R. Blackburn, PhD, FACMG, and Selene C. Koo, MD, PhD, from the Department of Pathology at St. Jude Children’s Research Hospital.

September

24

Germline Variants in Lung Cancer Cases

11:00am - 12:00pm ET

Join Dr. Moushumi Suryavanshi as she delves into the genetic complexities of lung cancer through four compelling cases. She'll highlight the interplay between germline variants, driver mutations, and resistance mutations, emphasizing the necessity for dynamic, personalized treatment approaches and the critical role of genetic profiling in improving patient outcomes.